Syntopix Group Plc Company Profile - Aug 07, 2011

Document Sample
Syntopix Group Plc Company Profile - Aug 07, 2011 Powered By Docstoc
					Company Fundamentals\Company Profile

   A Wright Investors' Service Research Report:

   Syntopix Group Plc
                                                                                           440 Wheelers Farms Road
                                                                                           Milford, CT 06461 U.S.A.


  COMPANY PROFILE
  Figures in Pounds Sterling

                                  Wright Quality Rating:LCNN                                 Key Data

   Syntopix Group plc is a research and development company, focusing on the                 Ticker:
   discovery of topical antimicrobials products in the cosmetic consumer healthcare and      SYGR
   pharmaceutical markets. The principal activity of the Company is the research,
   discovery and development of compounds for use in both medicinal and consumer             2010 Sales:
   healthcare markets principally in the areas of acne, oral hygiene and hair care. As of
                                                                                             151,000
   July 31, 2010, the Company's compounds included SYN0126, SYN0040, SYN1113 and
   SYN0129. As of July 31, 2010, the Company had a library of over 3,000 compounds.
   The wholly owned subsidiaries of the Company include Syntopix Limited and Syntopix        Major Industry:
   Services Limited.                                                                         Drugs, Cosmetics & Health
                                                                                             Care
                       Stock Chart                                    Officers
                                                               Non Executive Chairman
                                                                   Tom Bannatyne             Sub Industry:
                                                                                             Ethical Drug Manufacturers
                                                           Executive Director & Chief
                                                                   Executive                 Country:
                                                              Dr. Stephen P. Jones           United Kingdom

                                                               Chief Financial Officer &     Currency:
                                                                      Secretary              Pounds Sterling
                                                                  J. Darren Bamforth
                                                                                             Fiscal Year Ends:
                                                                                             July

                                                                                             Employees
                                                                                             16

                                                                                             Exchanges:
                                                                                             LON

            Stock Price (8/5/2011): 4.25 p                                                   Share Type:
              Recent stock performance                                        
				
DOCUMENT INFO
Description: Syntopix Group plc is a research and development company, focusing on the discovery of topical antimicrobials products in the cosmetic consumer healthcare and pharmaceutical markets. The principal activity of the Company is the research, discovery and development of compounds for use in both medicinal and consumer healthcare markets principally in the areas of acne, oral hygiene and hair care. As of July 31, 2010, the Company's compounds included SYN0126, SYN0040, SYN1113 and SYN0129. As of July 31, 2010, the Company had a library of over 3,000 compounds. The wholly owned subsidiaries of the Company include Syntopix Limited and Syntopix Services Limited.
BUY THIS DOCUMENT NOW PRICE: $24.95 100% MONEY BACK GUARANTEED
PARTNER Wright Investors' Service
Wright Investors' Service is an internationally recognized investment management and financial advisory firm headquartered in Milford, Connecticut. For more than 40 years, Wright has used well-defined and sophisticated investment strategies to help institutions, plan sponsors, bank trust departments, trust companies and individual investors achieve their financial objectives through a sensible approach to managing assets that balances risk and return.